BNP Paribas Fortis Private Equity: Funding, Team & Investors | Startup Intros

Loading organizations...

BNP Paribas Fortis Private Equity: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 4, 2025	MRM Health	$64.1M Series B	Jean-Patrick Hennebelle	Raf Moons, Goedele Ertveldt, Ackermans & van Haaren, Julian Zachmann, OMX Ventures, Qbic II
Nov 1, 2023	Vaultspeed	$16.0M Series A	Octopus Ventures, Paul Davidson	Dutch Founders Fund, Speedinvest, Marcel van der Heijden, PMV
Jul 1, 2023	Aphea.Bio	$77.0M Series C	Caaj Greebe	Astanor Ventures, Energy Impact Partners, AIF, Bill & Melinda Gates Foundation, David Devigne, SFPI-FPIM
Oct 1, 2022	MobieTrain	$9.0M Series B	Raf Moons, Renaat Berckmoes	Force Over Mass Capital, LRM
Aug 25, 2022	AstriVax	$29.9M Seed	Caroline Goddeeris, Shelley Margetson	Ackermans & van Haaren, Flanders Future Tech Fund, KU Leuven, Merieux Equity Partners, Thuja Capital
Jan 21, 2021	reMYND	$14.6M Series B Extension	—	FPIM, Korys, KU Leuven, PMV
Jun 16, 2020	etherna immunotherapies	$38.4M Series B	—	Boehringer Ingelheim, Fund+, Grand Decade, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital
Jun 16, 2020	Etherna	$38.4M Series B	—	Boehringer Ingelheim Venture Fund, Fund+, Grand Decade, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital
Sep 1, 2019	iSTAR Medical	$44.0M Series C	Bram Vanparys, PhD, MBA, Anne Portwich	EQT Life Sciences, Capricorn Venture Partners, Lionel Carnot, SFPI-FPIM, SRIW
Oct 2, 2015	Euroscreen	$18.0M Series B	Fund+, SFPI-FPIM	Capricorn Venture Partners, SRIW, Vesalius Biocapital